Almac

Almac launches SupplyTraQ technology solution

Wednesday, September 25, 2013 03:13 PM

Almac has launched SupplyTraQ, a web-based drug accountability and reconciliation tool that improves clinical trial drug supply management and simplifies post-trial administration. Compatible with IXRS, the company’s IVR/IWR technology, SupplyTraQ enables users to capture drug supply data in real-time and improve the accuracy of the supply management process. 

More... »

Almac launches TruSight tumor profiling next-generation sequencing service

Wednesday, September 11, 2013 01:37 PM

Almac has launched a tumor profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor panel as part of their biomarker discovery, development and delivery solutions.

More... »

Almac partners for cancer research in Northern Ireland

Friday, September 6, 2013 02:42 PM

Almac Discovery has announced a $20.2million partnership with the Center for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate cancer-focused drug discovery in Northern Ireland.

More... »

Almac expands, to create 229 jobs

Wednesday, June 12, 2013 02:12 PM

Craigavon-based Almac has announced a commercial manufacturing expansion. With the recent completion of a non-GMP drug development facility at the Craigavon site, this expansion represents a total investment of $10.3 million, including financial support from Invest Northern Ireland.  Up to 229 jobs will be created across both projects over the next three years.

More... »

Almac to host clinical trial workshop series

Wednesday, March 20, 2013 11:06 AM

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

More... »

Almac’s new U.S. commercial packaging operations pass FDA inspection

Wednesday, February 6, 2013 09:16 AM

Global service provider Almac has passed FDA inspection of its new U.S. commercial packaging operations located in Audubon, Penn. The inspection took place on Jan. 9 and 10, 2013, from which the regulatory body concluded that the site is fully compliant with Good Manufacturing Practices, with no 483 issued.

More... »

Almac completes Knowledge Transfer Partnership with Queens University

Wednesday, January 23, 2013 10:28 AM

Global service provider Almac has successfully completed the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis business. 

More... »

Almac doubles drug development capacity with a new non-GMP facility

Monday, January 14, 2013 10:11 AM

Global service provider Almac has expanded its drug product pharmaceutical development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at its U.K. headquarters in Craigavon.

More... »

Almac, TTP Labtech form alliance in fluorescence lifetime technology

Monday, January 7, 2013 11:53 AM

Global service provider Almac and TTP Labtech, a global developer and manufacturer of laboratory equipment, have formed an alliance in the field of fluorescence lifetime (FLT) technology to provide class leading screening performance. This will give customers of either party access to a broad range of biological applications coupled with the next generation of microplate reader technology.

More... »

Charlie Morris appointed to Almac’s clinical technologies executive team

Monday, December 17, 2012 04:01 PM

The Almac Group’s clinical technologies business unit has appointed Charlie Morris as vice president of new products and services. In this role, Morris will oversee the development of Almac’s IXRS technology and enhance the company’s metrics-based discipline to the software development process.

More... »